Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells-Reference-Cited by-同舟云学术

Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells

Published:2017-03-21 Issue:24 Volume:8 Page:38811-38824
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Xia Wei¹,Lo Chung Mau¹,Poon Randy Y.C.²,Cheung Tan To¹,Chan Albert C.Y.¹,Chen Lin¹,Yang Sitian¹,Tsao George S.W.³,Wang Xiao Qi¹⁴

Affiliation:

1. Department of Surgery, The University of Hong Kong, Hong Kong, China

2. Division of Life Science, Center for Cancer Research, and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China

3. School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China

4. State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma;Drug Resistance Updates;2024-05

2. Cancer stem cells—Challenges for cancer therapies;Cancer Epigenetics and Nanomedicine;2024

3. Cancer stem cells and their niche in cancer progression and therapy;Cancer Cell International;2023-12-01

4. Cancer stem cells: Signaling pathways and therapeutic targeting;MedComm – Oncology;2023-12

5. Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow;Biomedicine & Pharmacotherapy;2023-11